McKee Amy E Acquires 644 Shares of Common Stock in BIOCRYST PHARMACEUTICALS INC

Amy E. McKee, a director at BIOCRYST PHARMACEUTICALS INC (BCRX), acquired 644 shares of common stock on August 31, 2026. The shares were acquired in lieu of 50% of her quarterly cash Board Member retainer, with a reported value of $9.70 per share. This transaction increases her post-transaction holdings to 47,821 shares. The filing was signed by Alane P. Barnes, by power of attorney, on September 2, 2026.